These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10765044)

  • 1. Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration.
    Hirono N; Ishii K; Sasaki M; Kitagaki H; Hashimoto M; Imamura T; Tanimukai S; Hanihara T; Kazui H; Mori E
    Dement Geriatr Cogn Disord; 2000; 11(3):139-46. PubMed ID: 10765044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
    Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks DJ; Shibasaki H
    Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of brain perfusion in corticobasal degeneration and Alzheimer's disease.
    Okuda B; Tachibana H; Kawabata K; Takeda M; Sugita M
    Dement Geriatr Cogn Disord; 2001; 12(3):226-31. PubMed ID: 11244217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and neuropsychological features of corticobasal degeneration.
    Belfor N; Amici S; Boxer AL; Kramer JH; Gorno-Tempini ML; Rosen HJ; Miller BL
    Mech Ageing Dev; 2006 Feb; 127(2):203-7. PubMed ID: 16310834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of glucose metabolism in corticobasal degeneration.
    Taniwaki T; Yamada T; Yoshida T; Sasaki M; Kuwabara Y; Nakagawa M; Mihara F; Motomura S; Shigetou H; Kira J
    J Neurol Sci; 1998 Nov; 161(1):70-6. PubMed ID: 9879684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease.
    Josephs KA; Whitwell JL; Boeve BF; Knopman DS; Petersen RC; Hu WT; Parisi JE; Dickson DW; Jack CR
    Mov Disord; 2010 Jul; 25(9):1246-52. PubMed ID: 20629131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration.
    Henkel K; Karitzky J; Schmid M; Mader I; Glatting G; Unger JW; Neumaier B; Ludolph AC; Reske SN; Landwehrmeyer GB
    Mov Disord; 2004 Jul; 19(7):817-821. PubMed ID: 15254941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-based distribution of metabolic impairment in corticobasal degeneration.
    Garraux G; Salmon E; Peigneux P; Kreisler A; Degueldre C; Lemaire C; Destée A; Franck G
    Mov Disord; 2000 Sep; 15(5):894-904. PubMed ID: 11009197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A lateralized reduction of NAA in a case of corticobasal degeneration (CBD): application of proton magnetic resonance spectroscopy (1H-MRS)].
    Nakase T; Mizuno T; Takanashi Y; Nakajima K; Imahori Y; Furuya S; Naruse S
    No To Shinkei; 1998 May; 50(5):421-5. PubMed ID: 9621363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
    Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
    J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
    Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.
    Hu WT; Rippon GW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Josephs KA
    Mov Disord; 2009 Jul; 24(9):1375-9. PubMed ID: 19425061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.